Skip to main content
. 2023 Oct 17;12:e82618. doi: 10.7554/eLife.82618

Appendix 3—table 3. Covariate description.

Covariate description Variable name Covariate values Additional details
Race/ethnicity including Asian der_race_v2 Hispanic; Non-Hispanic AAPI; Non-Hispanic Black; Non-Hispanic White; Other
Age with imputation for categoricals der_age_trunc Years (continuous 18–89; patients noted to be greater than 89 are set to be age = 90)
Insurance type der_insurance Medicaid alone; Medicare alone; Medicare/Medicaid ± other; Other government ± other; Private ± other; Uninsured; Unknown
Derived variable for smoking status collapsing the current/former smoker variables der_smoking2 Never; Current or Former; Unknown
Binary obesity (BMI ≥ 30 or checkbox checked) indicator der_obesity 0=No; 1=Yes; 99=Unknown
Cardiovascular comorbidity (CAD, CHF, Afib, arrhythmia NOS, PVD, CVA, cardiac disease NOS) der_card 0=No; 1=Yes; 99=Unknown
Derived variable indicating whether patient has pulmonary comorbidities der_pulm 0=No; 1=Yes; 99=Unknown
Renal comorbidities der_renal 0=No; 1=Yes; 99=Unknown
Derived variable indicating whether patient has diabetes mellitus der_dm2 0=No; 1=Yes; 99=Unknown
Performance status der_ecogcat2 ECOG 0, 1, or 2+
Breast biomarkers combined variable der_breast_biomarkers 1=ER + ; 2=ER + /HER2+; 3=HER2+; 4=triple negative; 99=Unknown
Derived variable indicating cancer status
(splits remission/NED by cancer timing)
der_cancer_status_v4 0 - Remission/NED, remote; 1 - Remission/NED, recent; 2 - Active, responding; 3 - Active, stable; 4 - Active, progressing; 99 - Unknown
Timing of cancer treatment relative to COVID-19, collapsed der_cancer_tx_timing_v2 0=more than 3 months; 1=0–4 weeks; 2=1–3 months (*); 88=never or after COVID-19 diagnosis; 99=unknown
No cancer treatment in the 3 months prior to COVID-19 der_cancertr_none 0=No; 1=Yes; 99=Unknown Derived with the following covariates: der_any_cyto, der_any_targeted, der_any_endo, der_any_immuno, der_any_local, der_any_other
Coded as 1 if all these variables are 0; coded as 0 if any of these variables is 1; coded as 99 if any of these variables is 99; otherwise, NA
Any cytotoxic cancer treatment in the 3 months prior to COVID-19 der_any_cyto 0=No; 1=Yes; 99=Unknown
Any targeted therapy in the 3 months prior to COVID-19 der_any_targeted 0=No; 1=Yes; 99=Unknown
Any targeted therapy includes an anti-HER2 therapy in the 3 months prior to COVID-19 der_her2_3 m 0=No; 1=Yes Derived with der_her2, der_any_targeted.
Coded as 1 if der_any_targeted is 1 and der_her2 is 1
Coded as 0 if: a. der_any_targeted is 1 and der_her2 is 0
der_any_targeted is 1
Otherwise, NA der_her2:
0=No; 1=Yes
Any targeted therapy includes a CDK4/6 inhibitor therapy in the 3 months prior to COVID-19 der_cdk46i_3 m 0=No; 1=Yes Derived with der_cdk46i, der_any_targeted.
Coded as 1 if der_any_targeted is 1 and der_cdk46i is 1
Coded as 0 if: a. der_any_targeted is 1 and der_cdk46i is 0
der_any_targeted is 1
Otherwise, NA der_cdk46i:
0=No; 1=Yes
Any other targeted therapy (not anti-HER2/CDK4/6 inhibitor) in the 3 months prior to COVID-19 der_other_3 m 0=No; 1=Yes Derived with der_targeted_not_her2_cdk46i, der_any_targeted.
Coded as 1 if der_any_targeted is 1 and der_targeted_not_her2_cdk46i is 1
Coded as 0 if: a. der_any_targeted is 1 and der_targeted_not_her2_cdk46i is 0
der_any_targeted is 1
Otherwise, NA der_targeted_not_her2_cdk46i:
0=No; 1=Yes
Any endocrine therapy in the 3 months prior to COVID-19 der_any_endo 0=No; 1=Yes; 99=Unknown
Any immunotherapy in the 3 months prior to COVID-19 der_any_immuno 0=No; 1=Yes; 99=Unknown
Any local therapy (surgery or RT) within 3 months der_any_local 0=No; 1=Yes; 99=Unknown
Any other cancer therapy in the 3 months prior to COVID-19 der_any_other 0=No; 1=Yes; 99=Unknown
Region of patient residence with ex-US collapsed der_region_v2 Non-US; Other; Undesignated US; US Midwest; US Northeast; US South; US West
Trimester and year of diagnosis, using the most recent side of the interval as anchor der_tri_rt_dx T1 2020; T2 2020; T3 2020; T1 2021
What type of area does the patient primarily reside in? urban_rural1 1, Urban (city) | 2, Suburban (town, suburbs) | 3, Rural (country) | 88, Other | 99, Unknown
The type of health care center providing the patient’s data der_site_type AMC = academic medical center; CP = community practice; TCC = tertiary care center
Initial severity and course of illness severity_of_covid_19_v21 1, Mild (no hospitalization required) | 2, Moderate (hospitalization indicated) | 3, Severe (ICU admission indicated) | 99, Unknown
Derived treatment intent der_tr_intent Unknown Treatment; Not on Treatment; Palliative; Curative; Missing
Unknown Treatment and Missing were collapsed for analysis
Derived with der_anytx and treatment_intent:
Coded as ‘Unknown Treatment’ if der_anytx is NA or 99;
Coded as ‘Not on Treatment’ if der_anytx is 0
Coded as ‘Palliative’ if der_anytx is 1 and treatment_intent is 2
Coded as ‘Curative’ if der_anytx is 1 and treatment_intent is 1
Otherwise, Missing der_anytx:
0=No; 1=Yes; 99=Unknown
Treatment_intent: 1, Curative | 2, Palliative | 99, Unclear or unknown
Most recent line of cancer treatment, including systemic and non-systemic therapies der_txline Untreated in last 12 months; Curative NOS; First line; Non-curative NOS; Other; Second line or greater; Unknown
Hematologic malignancy indicator der_heme 0=No; 1=Yes